Page 137 - 《中国药房》2024年2期

础，提高其对TDM的重视程度，并对护理人员开展不良 [J]. Bioanalysis，2016，8（21）：2219-2234.
反应上报工作培训，掌握不良反应上报及应对措施。通 [13] GUO T D，OSWALD L M，MENDU D R，et al. Determi‐
过临床团队的共同努力，使 LEV 的应用更加规范合理， nation of levetiracetam in human plasma/serum/saliva by
减少癫痫患者的毒副反应。此外，由于目前我国尚无 liquid chromatography-electrospray tandem mass spec‐
trometry[J]. Clin Chim Acta，2007，375（1/2）：115-118.
LEV强制危急值报告制度，对于可能会引起严重不良反
[14] YEAP L L，LO Y L. Rapid and simultaneous quantifica‐
应或中毒的浓度阈值，还需要开展更多临床研究加以
tion of levetiracetam and its carboxylic metabolite in hu‐
确定。
man plasma by liquid chromatography-tandem mass spec‐
参考文献
trometry[J]. PLoS One，2014，9（11）：e111544.
[ 1 ] ALRABIAH H. Levetiracetam[J]. Profiles Drug Subst [15] JUENKE J M，BROWN P I，JOHNSON-DAVIS K L，et
Excip Relat Methodol，2019，44：167-204. al. Simultaneous quantification of levetiracetam and gaba‐
[ 2 ] MANREZA M L G，PAN T A，CARBONE E Q，et al. Effi‐ pentin in plasma by ultra-pressure liquid chromatography
cacy and safety of levetiracetam as adjunctive therapy for coupled with tandem mass spectrometry detection[J]. Ther
refractory focal epilepsy[J]. Arq Neuropsiquiatr，2021，79 Drug Monit，2011，33（2）：209-213.
（4）：290-298. [16] BLONK M I，VAN DER NAGEL B C，SMIT L S，et al.
[ 3 ] LYSENG-WILLIAMSON K A. Levetiracetam：a review Quantification of levetiracetam in plasma of neonates by
of its use in epilepsy[J]. Drugs，2011，71（4）：489-514. ultra performance liquid chromatography-tandem mass
[ 4 ] PATSALOS P N. Clinical pharmacokinetics of levetirace‐ spectrometry[J]. J Chromatogr B Analyt Technol Biomed
tam[J]. Clin Pharmacokinet，2004，43（11）：707-724. Life Sci，2010，878（7/8）：675-681.
[ 5 ] SHAH N M，HAWWA A F，MILLERSHIP J S，et al. A [17] QI Y J，LIU G X. A UPLC-MS/MS method for simulta-
simple bioanalytical method for the quantification of anti‐ neous determination of nine antiepileptic drugs in human
epileptic drugs in dried blood spots[J]. J Chromatogr B plasma and its application in TDM[J]. Biomed Chro‐
Analyt Technol Biomed Life Sci，2013，923/924：65-73. matogr，2021，35（7）：e5090.
[ 6 ] MIN K L，RYU J Y，CHANG M J. Development and clini‐ [18] GREINER-SOSANKO E，GIANNOUTSOS S，LOWER
cal applications of the dried blood spot method for thera‐ D R，et al. Drug monitoring：simultaneous analysis of la‐
peutic drug monitoring of anti-epileptic drugs[J]. Basic motrigine，oxcarbazepine，10-hydroxycarbazepine，and
Clin Pharmacol Toxicol，2019，125（3）：215-236. zonisamide by HPLC-UV and a rapid GC method using a
[ 7 ] PATSALOS P N，GHATTAURA S，RATNARAJ N，et al. nitrogen-phosphorus detector for levetiracetam[J]. J Chro‐
In situ metabolism of levetiracetam in blood of patients matogr Sci，2007，45（9）：616-622.
with epilepsy[J]. Epilepsia，2006，47（11）：1818-1821. [19] NIKOLAOU P，PAPOUTSIS I，DONA A，et al. Develop‐
[ 8 ] BIANCHI V，ARFINI C，VIDALI M. Therapeutic drug ment and validation of a GC/MS method for the simulta-
monitoring of levetiracetam：comparison of a novel immu‐ neous determination of levetiracetam and lamotrigine in
noassay with an HPLC method[J]. Ther Drug Monit， whole blood[J]. J Pharm Biomed Anal，2015，102：25-32.
2014，36（5）：681-685. [20] ANTONILLI L，BRUSADIN V，FILIPPONI F，et al. De‐
[ 9 ] TAN J，PAQUETTE V，LEVINE M，et al. Levetiracetam velopment and validation of an analytical method based
clinical pharmacokinetic monitoring in pediatric patients on high performance thin layer chromatography for the si‐
with epilepsy[J]. Clin Pharmacokinet，2017，56（11）： multaneous determination of lamotrigine，zonisamide and
1267-1285. levetiracetam in human plasma[J]. J Pharm Biomed Anal，
[10] CONTIN M，MOHAMED S，ALBANI F，et al. Simple 2011，56（4）：763-770.
and validated HPLC-UV analysis of levetiracetam in de‐ [21] EL-YAZBI A F，WAGIH M M，IBRAHIM F，et al. Spec‐
proteinized plasma of patients with epilepsy[J]. J Chro‐ trofluorimetric determination of topiramate and levetirace‐
matogr B Analyt Technol Biomed Life Sci，2008，873（1）： tam as single components in tablet formulations and in hu‐
129-132. man plasma and simultaneous fourth derivative synchro‐
[11] ENGELBRECHT L，GROBLER C J，RHEEDERS M. A nous fluorescence determination of their co-adminstered
simple and cost-effective HPLC-UV method for the detec‐ mixture in human plasma[J]. J Fluoresc，2016，26（4）：
tion of levetiracetam in plasma/serum of patients with 1225-1238.
epilepsy[J]. Biomed Chromatogr，2017，31（10）：10.1002/ [22] PATSALOS P N，BERRY D J，BOURGEOIS B F，et al.
bmc.3969. Antiepileptic drugs：best practice guidelines for therapeu‐
[12] IBRAHIM F A，EL-YAZBI A F，BARARY M A，et al. tic drug monitoring：a position paper by the subcommis‐
Sensitive inexpensive HPLC determination of four antiepi‐ sion on therapeutic drug monitoring，ILAE Commission
leptic drugs in human plasma：application to PK studies on Therapeutic Strategies[J]. Epilepsia，2008，49（7）：

中国药房 2024年第35卷第2期 China Pharmacy 2024 Vol. 35 No. 2 · 255 ·